APPENDIX B: ASPE PUBLIC HEALTH LABORATORY INTERVIEW LIST

Interviewees

Federal Contacts:

Rosemary Bakes-Martin Supervisory Health Scientist Division of Laboratory Systems Centers for Disease Control and Prevention	Anthony Moulton, Ph.D Manager Public Health Information Systems Public Health Program Practice Office Center for Disease Control and Prevention
Joseph Boone, Ph.D. Assistant Director of Science Division of Laboratory Systems Public Health Practice Program Office Centers for Disease Control and Prevention	Stuart Nightingale, M.D. Associate Commissioner for Health Affairs Office of Health Affairs Food and Drug Administration
Michael Friedman, M.D. Acting Director Food and Drug Administration	Albert E. Pohland, Ph.D. Strategic Manager for Research Liaison Center for Foods Food and Drug Administration
Robert Lake Division Director Office of Policy Planning and Strategic Direction Center for Food Safety and Applied Nutrition Food and Drug Administration	Jane Suen Health Systems Analyst Division of Public Health Systems Public Health Practice Program Office Centers for Disease Control and Prevention
Joseph Madden Division Director Strategic Manager for Microbiology Center for Foods Food and Drug Administration

State Public Health Laboratory Contacts:

Russell Alexander, M.D. Chief of Epidemiology Seattle King County Health Department	John Hunt, Ph.D. Clinical Unit Leader Public Health Laboratory Minnesota Department of Health
Carl Blank, Dr.P.H. Acting Executive Director Association of State and Territorial Public Health Laboratory Directors	Stan Inhorn, M.D. Medical Director Wisconsin State Laboratory of Hygiene
Pauline Bouchard, J.D., M.P.H. Public Health Laboratory Director Minnesota Department of Health	Michael Kimberly, Dr.P.H. Director of Laboratory Services Tennessee Department of Health
Henry Bradford, Jr. Ph.D. State Public Health Laboratory Director Office of Public Health Louisiana Department of Health and Hospitals	Robert Martin, Dr.P.H. Director Bureau of Laboratories Michigan Department of Community Health
Ron Cada, Dr.P.H. Director Colorado Division of Laboratories Department of Public Health	David Maserang, Ph.D. Bureau Chief Bureau of Laboratories Texas Department of Health
Jon Counts, Dr.P.H. Assistant Secretary Public Health Laboratory Washington State Department of Health	Marion E. Pierce Director, Public Health Laboratory Division of Public Health Services New Jersey Department of Health and Senior Services
Jack DeBoy, Dr.P.H. Deputy Director Public Health Laboratory Maryland Department of Health	Ralph Timperi, M.P.H. Director State Laboratory Institute Massachusetts Department of Public Health
Arthur Di Salvo, M.D. Bureau Chief Bureau of Laboratory Services Nevada State Health Division	Michael Volz, Ph.D. Assistant Deputy Director Laboratory Science California State Department of Health Services
Francis Downs, Dr.P.H. Managed Care Coordinator Bureau of Laboratories Michigan Department of Community Health	Burt Wilcke, Jr., Ph.D. Director State Public Health Laboratory Vermont State Department of Health (President, ASTPHLD)
Charles Hartwig, Sc.D. Chief Office of Laboratory Sciences Florida Department of Health and Rehabilitative Services	Ann Whilley, Ph.D. Director Division of Laboratory, Quality, and Certification New York State Department of Health

Other Contacts:

Gary Anderson Chief Executive Officer Epic Information Systems	Scott Merwin Medical Administrator M-Care Health Plan University of Michigan
Earl C. Buck Chief Executive Officer System Labs Samaritan Health Systems	Mike Osterholm, M.P.H., Ph.D. Chief Acute Disease Epidemiology Section Minnesota State Department of Health
Thomas Chapel Consultant MACRO International	Paul Pomerantz Executive Vice President Clinical Laboratory Management Association
Robert P. DeCresce, M.D. Director Rush-Presbyterian-St. Luke's Medical Center Laboratory	Lois Quinlan Associate Executive Director Operations and Finance Association of State and Territorial Public Health Laboratory Directors
Chris Dimitry Contracting Administrator M-Care Health Plan University of Michigan	Gary Sawyer, M.S. Laboratory X-Ray Services Administrator Multnomah County Public Health Laboratory
Willis Forrester Executive Director Council of State and Territorial Epidemiologists	Marc D. Silverstein, M.D. Director Center for Healthcare Research Medical University of South Carolina
Bruce Friedman, M.D. Professor of Pathology University of Michigan Medical School	Perry Smith Director Division of Epidemiology New York State Department of Health
Greg Gilmet, M.D. Associate Medical Director Blue Care Network of Southeast Michigan	Paul Stehr-Green, Dr.P.H. State Epidemiologist Washington State Department of Health
Grace Gorenflo Project Manager National Association of County and City Health Officials	David Sundwall, M.D. President American Clinical Lab Association
Ed Kauffman, M.D. Vice President and National Medical Director SmithKline Beecham Diagnostics	Karen Troccoli, M.P.H. Project Manager National Association of County and City Health Officials
Joel Kelly Director Health Service Operations	Marianne Watters Administrative Director Parkland Memorial Hospital Laboratories
Peter Mallon, Ph.D. Vice President, Medical Applications Quest Laboratories (formerly Corning Labs)	Ronald Weiss, M.D., M.B.A. Senior Vice President and Director of Laboratories ARUP Laboratories
	Kim Willis Director of Patient Services Chartered Health Plan

Telephone Protocol for Public Health Laboratory Interviews

For State Officials:

How many public health labs does your state operate?

What is the public health infrastructure with respect to public health labs (e.g., personnel, expenditures, other resources)?

What (if any) contractual arrangements exist between public health labs and MCOs, and to what degree do the functions of MCOs and public health laboratories overlap?

What effect is managed care having on disease reporting (e.g., effects on compliance, timeliness, and accuracy of reporting)?

To what extent is managed care having a disease-specific effect on disease reporting?

How has managed care's presence in the area of laboratory services changed or affected the practices and/or functions of public health laboratories?

How is information shared between the public health labs and MCOs (e.g., information systems)?

Have evolving relationships between MCOs and public health laboratories contributed to the development and utilization of laboratory information systems (LIS), and have these efforts resulted in cost savings?

For Federal And Private Sector Contacts:

What services do public health laboratories and MCOs provide to each other, what (if any) contractual arrangements exist between these organizations, and to what degree do the functions of MCOs and public health laboratories overlap?

Do MCOs generally conduct some of these lab functions in house, or contract with other private labs for most diseases? For exotic diseases, what are the contractual stipulations between MCOs and PHLs?

What effect is managed care having on disease reporting (e.g., effects on compliance, timeliness, and accuracy of reporting) as MCOs subsume some public health functions?

How has managed care's presence in the area of laboratory services changed or affected the practices and/or functions of public health laboratories?

Do they have any data on changes in national PHL lab capacity or budgets before and after introduction to managed care?

How many states have LIS systems in place? Are they centralized in some form?

Are there any public-private partnerships in LIS development? Who funds what portion? Impact?

Which states would be good candidates for case studies of managed care penetration and public health laboratory capacity? Why?

Should we also look to target diseases for specific states/regions?

Are there related topics you have observed in the marketplace with respect to emerging or existing relationships between MCOs and public health that you think would be particularly important for us to explore?

Is there any literature or organizational contacts which you feel would be timely or helpful to the project team?

specific gray literature that might inform us of trends

contacts within managed care organizations for specific states

any "partnerships" which may serve as models for how these organizations can work together

identify areas of potential "partnerships," and what each of the partners could bring to the table

identify barriers to collaboration

Return to Table of Contents